NKG2D CAR T-cell therapy inhibits the growth of NKG2D ligand heterogeneous tumors.
Spear P; Barber A; Rynda-Apple A; Sentman CL; Immunology And Cell Biology, 2013, vol. 91, issue 6, p 435, ISSN 14401711. ISBN 14401711.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef